• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Protara Therapeutics (TARA)

Common Shares
Sell: $4.99|Buy: $5.59|Change: 0.14 (-2.73%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support,or PS, which includes both nutrition and fluids.

Address

1 Little West 12th Street
New York
NY
USA
10014

Telephone

+1 646 8440337

Website

https://www.protaratx.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Protara Therapeutics Inc Fourth Quarter Earnings Results for 20262027-03-10T00:00:00
Protara Therapeutics Inc Annual Report for 20262027-03-10T00:00:00
Protara Therapeutics Inc Third Quarter Earnings Results for 20262026-11-10T00:00:00
Protara Therapeutics Inc Second Quarter Earnings Results for 20262026-08-11T00:00:00
Protara Therapeutics Inc Annual General Meeting for 20262026-06-11T12:00:00
Protara Therapeutics Inc First Quarter Earnings Results for 20262026-05-08T00:00:00

Previous key dates

NameKey Date
Protara Therapeutics Inc Fourth Quarter Earnings Results for 20252026-03-10T00:00:00
Protara Therapeutics Inc Annual Report for 20252026-03-10T00:00:00
TD Cowen 46th Annual Health Care Conference2026-03-03T14:30:00
Oppenheimer 36th Annual Healthcare Life Sciences Conference2026-02-26T14:40:00
Protara Therapeutics ASCO-GU Update2026-02-24T08:00:00
44(th) Annual J.P. Morgan Healthcare Conference2026-01-14T15:45:00
Protara Therapeutics SUO Update Call2025-12-03T08:30:00
Protara Therapeutics Update Call2025-11-19T08:30:00
Protara Therapeutics Inc Third Quarter Earnings Results for 20252025-11-10T00:00:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-09T09:00:00
Cantor Global Healthcare Conference2025-09-04T13:35:00
Protara Therapeutics Inc Second Quarter Earnings Results for 20252025-08-11T00:00:00
Protara Therapeutics Inc Annual General Meeting for 20252025-06-11T12:00:00
TD Cowen 6th Annual Oncology Innovation Summit2025-05-27T13:30:00
H.C. Wainwright & Co. 3rd Annual BioConnect Investor Conference2025-05-20T12:30:00
Protara Therapeutics Inc First Quarter Earnings Results for 20252025-05-08T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.